In­tel­lia Ther­a­peu­tics cuts 15% of work­force, ex­tends cash run­way in­to mid-2026

In­tel­lia Ther­a­peu­tics an­nounced Thurs­day that it is cut­ting 15% of its work­force and paus­ing cer­tain re­search pro­grams fol­low­ing an in­ter­nal re­view.

A rep­re­sen­ta­tive for In­tel­lia told End­points News that the com­pa­ny cut po­si­tions across all de­part­ments, though it won’t im­pact its lead pro­grams and can­di­dates. The pro­grams that In­tel­lia is end­ing “would gen­er­al­ly be undis­closed tar­gets/projects that were much ear­li­er in the re­search process,” ac­cord­ing to the rep­re­sen­ta­tive.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER